Effect of the Nasal Provocation on the Breathing Style
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to find out how the provocation of the nose changes breathing style (specifically, frequency and tidal volume changes)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 21, 2014
CompletedFirst Posted
Study publicly available on registry
May 23, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedMay 23, 2014
May 1, 2014
3 months
May 21, 2014
May 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
breathing style
frequence and volume of breathing measured with spirometry and respiratory effort belts
continuously during 2 hours
Secondary Outcomes (2)
thorax - abdomen relation
continuously during 2 hours
activation of the autonomous nervous system
continuously during 2 hours
Study Arms (1)
Allergen and xylometatsolin
EXPERIMENTALTwo separate exposure sessions: 1) nasal birch pollen exposure 2) nasal xylometazoline exposure
Interventions
Aquagen SQ 10 000 SQ/ml nasal exposure Xylometazoline 1 mg/ml nasal exposure
Eligibility Criteria
You may qualify if:
- Birch pollen allergic subjects must have clear nasal symptoms during the birch pollen season and birch specific IgE \>= 0.70
- Healthy subjects: birch specific IgE \< 0.35
- The subjects are not allowed to be under medication that affects the function of their nose during a specific time period before the measurement
- They have to be free of any acute respiratory symptoms during the prior two weeks to the measurements
- Before measurement, they are not allowed to have heavy meal or sport
- They are not allowed to have caffeine or other stimulants for 12 hours or alcohol for 24 hours.
You may not qualify if:
- Heart diseases
- Brain circulatory disorders
- Surgical operations of nose
- Chronic nasal symptoms
- Pregnancy
- Smoker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oulu University hospital, dept of Otorhinolaryngology
Oulu, Oulu, FIN-90120, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tiina M Seppänen, PhD
University of Oulu
- PRINCIPAL INVESTIGATOR
Miia-Liisa Vakkuri, Med Cand
University of Oulu
- STUDY CHAIR
Tapio Seppänen, Prof
University of Oulu
- STUDY CHAIR
Olli-Pekka Alho, Prof
University of Oulu
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2014
First Posted
May 23, 2014
Study Start
March 1, 2014
Primary Completion
June 1, 2014
Study Completion
June 1, 2016
Last Updated
May 23, 2014
Record last verified: 2014-05